These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 10475177)

  • 1. Typhoid fever and childhood vaccine strategies.
    Griffin GE
    Lancet; 1999 Aug; 354(9180):698-9. PubMed ID: 10475177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typhoid fever in children aged less than 5 years.
    Sinha A; Sazawal S; Kumar R; Sood S; Reddaiah VP; Singh B; Rao M; Naficy A; Clemens JD; Bhan MK
    Lancet; 1999 Aug; 354(9180):734-7. PubMed ID: 10475185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
    Cook J; Jeuland M; Whittington D; Poulos C; Clemens J; Sur D; Anh DD; Agtini M; Bhutta Z;
    Vaccine; 2008 Nov; 26(50):6305-16. PubMed ID: 18835415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy.
    Bahl R; Sinha A; Poulos C; Whittington D; Sazawal S; Kumar R; Mahalanabis D; Acosta CJ; Clemens JD; Bhan MK
    J Health Popul Nutr; 2004 Sep; 22(3):304-10. PubMed ID: 15609783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New generation typhoid vaccines: an effective preventive strategy to control typhoid fever in developing countries.
    Verma R; Bairwa M; Chawla S; Prinja S; Rajput M
    Hum Vaccin; 2011 Aug; 7(8):883-5. PubMed ID: 21791973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.
    Khan MI; Soofi SB; Ochiai RL; Habib MA; Sahito SM; Nizami SQ; Acosta CJ; Clemens JD; Bhutta ZA;
    Vaccine; 2012 Aug; 30(36):5389-95. PubMed ID: 22721899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of typhoid vaccines in Asia: the DOMI experience.
    Ochiai RL; Acosta CJ; Agtini M; Bhattacharya SK; Bhutta ZA; Do CG; Dong B; Chen X; Stanton B; Kaljee L; Nyamete A; Galindo CM; von Seidlein L; DeRoeck D; Jodar L; Clemens JD
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S34-8. PubMed ID: 17582567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
    Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
    J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Typhoid vaccine: a case for inclusion in national program.
    Sharma P; Taneja DK
    Indian J Public Health; 2011; 55(4):267-71. PubMed ID: 22298135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age for typhoid vaccination.
    John TJ
    Indian Pediatr; 1997 Jul; 34(7):649. PubMed ID: 9401263
    [No Abstract]   [Full Text] [Related]  

  • 12. Opportunities for Typhoid Vaccination in India.
    Srinivasan M; Sindhu KN; John J; Kang G
    Indian Pediatr; 2019 Jun; 56(6):453-458. PubMed ID: 31278221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typhoid vaccination: the Asian experience.
    DeRoeck D; Ochiai RL; Yang J; Anh DD; Alag V; Clemens JD
    Expert Rev Vaccines; 2008 Jul; 7(5):547-60. PubMed ID: 18564010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of oral killed typhoid vaccine.
    Chuttani CS; Prakash K; Vergese A; Sharma U; Singha P; Ray BG
    Bull World Health Organ; 1971; 45(4):445-50. PubMed ID: 4948415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low- and middle-income countries to support vaccine introduction policy and decisions.
    Mogasale V; Ramani E; Park IY; Lee JS
    Hum Vaccin Immunother; 2017 Sep; 13(9):2017-2024. PubMed ID: 28604164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community.
    Poulos C; Bahl R; Whittington D; Bhan MK; Clemens JD; Acosta CJ
    J Health Popul Nutr; 2004 Sep; 22(3):311-21. PubMed ID: 15609784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Sur D; Ochiai RL; Bhattacharya SK; Ganguly NK; Ali M; Manna B; Dutta S; Donner A; Kanungo S; Park JK; Puri MK; Kim DR; Dutta D; Bhaduri B; Acosta CJ; Clemens JD
    N Engl J Med; 2009 Jul; 361(4):335-44. PubMed ID: 19625715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Strategies and Incidence Thresholds for Vi Conjugate Vaccines Against Typhoid Fever: A Cost-effectiveness Modeling Study.
    Lo NC; Gupta R; Stanaway JD; Garrett DO; Bogoch II; Luby SP; Andrews JR
    J Infect Dis; 2018 Nov; 218(suppl_4):S232-S242. PubMed ID: 29444257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled field trials of three different oral killed typhoid vaccines in India.
    Chuttani CS
    Dev Biol Stand; 1976; 33():98-101. PubMed ID: 782977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live oral TY 21a--typhoid vaccine.
    Bhatia RS
    J Assoc Physicians India; 1993 Nov; 41(11):770, 773. PubMed ID: 8005959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.